Inventor · disambiguated record
Cheng Peng
Also filed as: PENG CHENG · PENG CHENG-YUAN
5 granted patents·8 pending applications·1 citations·filing 2011–2022
62Inventor score
Files withSUZHOU ARK BIOPHARMACEUTICAL CO LTD8ACADEMIA SINICA1NOVOZYMES AS1SHANGHAI ARK BIOPHARMACEUTICAL CO LTD1UNIV MEDICAL HOSPITAL CHINA1
Top patents by PatentIndex Score
13 records- 0165US8859573B2Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2WAN ZEHONG·Filed 2011·Granted Oct 14, 2014·1 cites·13 claims
- 0255US12103969B2Anti-Siglec antibody, pharmaceutical composition comprising the same, and uses thereofACADEMIA SINICA·Filed 2018·Granted Oct 1, 2024·0 cites·10 claims
- 0355US2025144220A1Conjugate for preventing and treating viral infections and use thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0451US2023293500A1Ak3287 preparation, and preparation method therefor and application thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0550US10717730B1Dihydroisoquinoline compoundSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 21, 2020·0 cites·6 claims
- 0649US12365699B2Elastase inhibitor prodrug and use thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 22, 2025·0 cites·20 claims
- 0749US2025026742A1Compound as atr kinase inhibitorSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0848US2022056387A1Nanoparticles based method for screening enzyme or microorganismNOVOZYMES AS·Filed 2019·Application pending·0 cites
- 0946US2023295159A1Atx inhibitor, and preparation method therefor and use thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1045US2020251214A1Liver Fibrosis Assessment Model, Liver Fibrosis Assessment System And Liver Fibrosis Assessment MethodUNIV MEDICAL HOSPITAL CHINA·Filed 2019·Application pending·0 cites
- 1142US2022387443A1Respiratory syncytial virus fusion protein inhibitor compositions and methods for the treatment and prophylaxis of rsv diseases using the sameSHANGHAI ARK BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1239US10647712B2Dihydroisoquinoline compoundSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted May 12, 2020·0 cites·26 claims
- 1339US2022081434A1Dihydroisoquinoline compoundSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cheng Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →